The 77,000-square-foot facility will manufacture the company’s industry-leading Xpert tuberculosis testing cartridges for India and other countries
Cepheid, a leading global molecular diagnostics company, today announced the launch of their first manufacturing unit in India at Mahadeva Kodigehalli, Bengaluru. The 77,000-square-foot facility will manufacture the company’s industry-leading Xpert tuberculosis testing cartridges for India and other countries.
The facility was inaugurated by Dr K Sudhakar, Minister for Health & Family Welfare and Medical Education, Government of Karnataka and Laurent Bellon, Senior VP, Operations, Cepheid USA in the presence of Srinath Venkatesh, President, Danaher India and Ravikumar Venkataraman, Vice President, Danaher India Development Center.
The launch of the new manufacturing unit in India represents a significant milestone for Cepheid, as it strengthens the company’s commitment to providing accessible and high-quality molecular diagnostic solutions to healthcare providers and patients in the region.
Dr Sudhakar said, “I would like to congratulate and thank Cepheid for choosing Karnataka for setting up its first manufacturing facility in South Asia.”
Laurent Bellon, Senior Vice President, Operations, Cepheid USA, said, “We are thrilled to announce the launch of our first manufacturing unit in India. The Make in India program represents our vision of furthering India’s growth and development in the molecular diagnostic ecosystem. We are proud to be a critical partner in the country’s efforts to improve healthcare outcomes and eliminate TB. This new manufacturing facility illustrates our strong commitment to India.”
“We are proud to contribute to India’s long-term sustainability goals and help eradicate TB by 2025”, said Jai Shankar Krishnan, President – High Growth Markets, Danaher Corporation. “We are excited to leverage the Make in India initiative by opening a manufacturing site in Bangalore for Cepheid that will help more than 10 million Indian population to be tested for TB along with other tropical diseases.”
Cepheid has almost 50,000 GeneXpert Systems installed globally, including systems across 35 states and union territories in India.
“The manufacturing site provides a fantastic Gemba for our product developers – understanding how our products are built helps us design next-generation products,” stated Venkataraman Ravikumar, Vice President, India Development Center. “And for the manufacturing teams, India Development Center (IDC) provides a window into future products and solutions that are anticipated in the market.”
